- Home
- GRVY vs AMRN Comparison
GRVY vs AMRN Comparison
Compare GRVY & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | AMRN |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | South Korea | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 339.8M |
| IPO Year | 2005 | 1998 |
Fundamental Metrics
Financial Performance| Metric | GRVY | AMRN |
|---|---|---|
| Price | $62.45 | $13.99 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 17.5K | ★ 82.1K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.05 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $53.12 | $0.35 |
| 52 Week High | $74.75 | $20.90 |
Technical Indicators
Market Signals| Indicator | GRVY | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 41.58 |
| Support Level | $62.10 | $13.65 |
| Resistance Level | $65.27 | $14.55 |
| Average True Range (ATR) | 2.40 | 0.75 |
| MACD | -0.54 | -0.10 |
| Stochastic Oscillator | 6.20 | 21.29 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.